Business
PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue
PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023 REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE)
About this update from Procept Biorobotics Corporation
[{"type":"text","content":"PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023\nREDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported preliminary unaudited revenue for the quarter and fiscal year ended December 31, 2022. Preliminary, Unaudited Revenue Highlights: Total revenue for the fourth quarter of 2022 is expected to be in the range of $23.6 million to $23.8 million, compared to $10.1 million in the prior year period Total U.S. revenue of $21.6 million to $21.8 million for the fourth quarter of 2022U.S. system sales of 28 robots, resulting in total U.S. system revenue of approximately $10.4 million to $10.5 million for the fourth quarter of 2022Total U.S. Handpiece and other consumables revenue of approximately $10.2 million to $10.4 million for the fourth quarter of 2022Total international revenue of approximately $2.0 million for the fourth quarter of 2022 Fiscal year 2022 revenue is expected to be approximately $74.8 million to $75.0 million, representing growth of approximately 117% compared to the prior year period The Company plans to report financial results for the fourth quarter and fiscal year 2022 after market close on Tuesday, February 28, 2023. The Company’s management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The preliminary results included in this press release are unaudited and remain subject to adjustment. Investors interested in listening to the conference call may do so by following one of the below links: Webcast link for interested listeners: https://edge.media-server.com/mmc/p/pbyn22v3 Dial-in registration for sell-side research analysts: https://register.vevent.com/register/BIac8fb5d0a7e245dd9f8c5ad7c0b22c2e Live audio of the webcast will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. An archived recording will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. The webcasts will be available for replay for at least 90 days after the event. About PROCEPT BioRobotics CorporationPROCEPT BioRobotics is a surgical rob...